Correction: Decreased risk of underdosing with continuous infusion versus intermittent administration of cefotaxime in patients with sickle cell disease and acute chest syndrome.
[This corrects the article DOI: 10.1371/journal.pone.0302298.].
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0319527 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849724133552685056 |
|---|---|
| author | Keyvan Razazi Enora Berti Jerome Cecchini Guillaume Carteaux Anoosha Habibi Pablo Bartolucci Romain Arrestier Ségolène Gendreau Nicolas de Prost Anne Hulin Armand Mekontso Dessap |
| author_facet | Keyvan Razazi Enora Berti Jerome Cecchini Guillaume Carteaux Anoosha Habibi Pablo Bartolucci Romain Arrestier Ségolène Gendreau Nicolas de Prost Anne Hulin Armand Mekontso Dessap |
| author_sort | Keyvan Razazi |
| collection | DOAJ |
| description | [This corrects the article DOI: 10.1371/journal.pone.0302298.]. |
| format | Article |
| id | doaj-art-123f04ae4ef44651b258562fd2f2fb7b |
| institution | DOAJ |
| issn | 1932-6203 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-123f04ae4ef44651b258562fd2f2fb7b2025-08-20T03:10:50ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01202e031952710.1371/journal.pone.0319527Correction: Decreased risk of underdosing with continuous infusion versus intermittent administration of cefotaxime in patients with sickle cell disease and acute chest syndrome.Keyvan RazaziEnora BertiJerome CecchiniGuillaume CarteauxAnoosha HabibiPablo BartolucciRomain ArrestierSégolène GendreauNicolas de ProstAnne HulinArmand Mekontso Dessap[This corrects the article DOI: 10.1371/journal.pone.0302298.].https://doi.org/10.1371/journal.pone.0319527 |
| spellingShingle | Keyvan Razazi Enora Berti Jerome Cecchini Guillaume Carteaux Anoosha Habibi Pablo Bartolucci Romain Arrestier Ségolène Gendreau Nicolas de Prost Anne Hulin Armand Mekontso Dessap Correction: Decreased risk of underdosing with continuous infusion versus intermittent administration of cefotaxime in patients with sickle cell disease and acute chest syndrome. PLoS ONE |
| title | Correction: Decreased risk of underdosing with continuous infusion versus intermittent administration of cefotaxime in patients with sickle cell disease and acute chest syndrome. |
| title_full | Correction: Decreased risk of underdosing with continuous infusion versus intermittent administration of cefotaxime in patients with sickle cell disease and acute chest syndrome. |
| title_fullStr | Correction: Decreased risk of underdosing with continuous infusion versus intermittent administration of cefotaxime in patients with sickle cell disease and acute chest syndrome. |
| title_full_unstemmed | Correction: Decreased risk of underdosing with continuous infusion versus intermittent administration of cefotaxime in patients with sickle cell disease and acute chest syndrome. |
| title_short | Correction: Decreased risk of underdosing with continuous infusion versus intermittent administration of cefotaxime in patients with sickle cell disease and acute chest syndrome. |
| title_sort | correction decreased risk of underdosing with continuous infusion versus intermittent administration of cefotaxime in patients with sickle cell disease and acute chest syndrome |
| url | https://doi.org/10.1371/journal.pone.0319527 |
| work_keys_str_mv | AT keyvanrazazi correctiondecreasedriskofunderdosingwithcontinuousinfusionversusintermittentadministrationofcefotaximeinpatientswithsicklecelldiseaseandacutechestsyndrome AT enoraberti correctiondecreasedriskofunderdosingwithcontinuousinfusionversusintermittentadministrationofcefotaximeinpatientswithsicklecelldiseaseandacutechestsyndrome AT jeromececchini correctiondecreasedriskofunderdosingwithcontinuousinfusionversusintermittentadministrationofcefotaximeinpatientswithsicklecelldiseaseandacutechestsyndrome AT guillaumecarteaux correctiondecreasedriskofunderdosingwithcontinuousinfusionversusintermittentadministrationofcefotaximeinpatientswithsicklecelldiseaseandacutechestsyndrome AT anooshahabibi correctiondecreasedriskofunderdosingwithcontinuousinfusionversusintermittentadministrationofcefotaximeinpatientswithsicklecelldiseaseandacutechestsyndrome AT pablobartolucci correctiondecreasedriskofunderdosingwithcontinuousinfusionversusintermittentadministrationofcefotaximeinpatientswithsicklecelldiseaseandacutechestsyndrome AT romainarrestier correctiondecreasedriskofunderdosingwithcontinuousinfusionversusintermittentadministrationofcefotaximeinpatientswithsicklecelldiseaseandacutechestsyndrome AT segolenegendreau correctiondecreasedriskofunderdosingwithcontinuousinfusionversusintermittentadministrationofcefotaximeinpatientswithsicklecelldiseaseandacutechestsyndrome AT nicolasdeprost correctiondecreasedriskofunderdosingwithcontinuousinfusionversusintermittentadministrationofcefotaximeinpatientswithsicklecelldiseaseandacutechestsyndrome AT annehulin correctiondecreasedriskofunderdosingwithcontinuousinfusionversusintermittentadministrationofcefotaximeinpatientswithsicklecelldiseaseandacutechestsyndrome AT armandmekontsodessap correctiondecreasedriskofunderdosingwithcontinuousinfusionversusintermittentadministrationofcefotaximeinpatientswithsicklecelldiseaseandacutechestsyndrome |